Recent Updates
Recently added Catalysts
HCM Neutral Sentiment Score: 60/100

Blocklisting Six Monthly Return Hong Kong, Shanghai, & Florham Park, NJ - Monday

Key Takeaway: HUTCHMED (China) Limited announced its six-monthly blocklisting return covering the period from June 29, 2025, to December 28, 2025. The company reported static figures in terms of the block scheme, with no increases since the last return. During this period, a total of 216,150 ordinary shares were allotted under the 2015 HUTCHMED Share Option Scheme, leaving a balance of 45,775,868 shares available for issuance at the end of the reporting period. The total number of securities issued rose to 872,327,620.

Market Sentiment Analysis

Full Press Release Details

Blocklisting Six Monthly Return
Hong Kong, Shanghai, & Florham Park, NJ - Monday, December 29, 2025: HUTCHMED (China) Limited ("HUTCHMED" or the "Company") (Nasdaq/AIM: HCM; HKEX: 13) announces the following blocklisting six monthly return:
1. Name of applicant: HUTCHMED (China) Limited
2. Name of scheme: Share Option Scheme conditionally adopted by HUTCHMED in 2015 ("2015 HUTCHMED Share Option Scheme")
3. Period of return: From June 29, 2025 to December 28, 2025
4. Balance under scheme from previous return: 2015 HUTCHMED Share Option Scheme: 45,992,018 ordinary shares of US$0.1 each
5. The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return: 2015 HUTCHMED Share Option Scheme: Nil
6. Number of securities issued/allotted under scheme during period: 2015 HUTCHMED Share Option Scheme: 216,150
7. Balance under scheme not yet issued/allotted at end of the period: 2015 HUTCHMED Share Option Scheme: 45,775,868 ordinary shares of US$0.1 each
8. Number and class of securities originally listed and the date of admission: 25,198,880 ordinary shares of US$0.1 each admitted on June 17, 2019 ( to replace the Company's previous block admission schemes following the Company's share subdivision which took effect on May 30, 2019)
9. Total number of securities in issue at the end of the period: 872,327,620 ordinary shares of US$0.1 each
Name of contact: Weiguo Su / Johnny Cheng
Address of contact: Level 18, The Metropolis Tower, 10 Metropolis Drive, Hung Hom, Kowloon, Hong Kong
Telephone number of contact: +852 2121 8200
Investor Enquiries +852 2121 8200 / ir@hutch-med.com
Media Enquiries
FTI Consulting - +44 20 3727 1030 / HUTCHMED@fticonsulting.com
Ben Atwell / Tim Stamper +44 7771 913 902 (Mobile) / +44 7421 898 348 (Mobile)
Brunswick - Zhou Yi +852 9783 6894 (Mobile) / HUTCHMED@brunswickgroup.com
Panmure Liberum Nominated Advisor and Joint Broker
Atholl Tweedie / Emma Earl / Rupert Dearden +44 20 7886 2500
Cavendish Joint Broker
Geoff Nash / Nigel Birks +44 20 7220 0500
Deutsche Numis Joint Broker
Freddie Barnfield / Jeffrey Wong / Duncan Monteith +44 20 7260 1000

Frequently Asked Questions

What is the name of the applicant for the blocklisting?

The applicant is HUTCHMED (China) Limited.

What is the period covered by the latest return?

The period covered is from June 29, 2025, to December 28, 2025.

How many shares were issued during this period?

A total of 216,150 shares were issued under the scheme.

What is the balance of shares unissued at period's end?

The balance not yet issued is 45,775,868 shares.

When were shares originally listed and how many?

25,198,880 shares were listed on June 17, 2019.

Last updated: Dec 29, 2025